Leaflet DORZOLAMIDA/TIMOLOL DR GERHARD MANN 20mg / 5mg / ml ophthalmic drops solution

Indicated for: glaucoma; ocular hypertension

Route of administration: ophthalmic

Substance: dorzolamide + timolol (glaucoma agent + beta blocker)

ATC: S01ED51 (Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents)

Precautions:
Dizziness / vertigo
Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Hypotension / fall risk
Hypotension / fall risk

May lower blood pressure and increase the risk of falls.

Elderly warning
Elderly warning

Older people may have an increased risk of side effects.

The combination of Dorzolamide + timolol is used for the treatment of glaucoma and ocular hypertension in patients who do not respond adequately to monotherapy. Dorzolamide is a carbonic anhydrase inhibitor, and Timolol is a beta-blocker; together, they reduce intraocular pressure through complementary mechanisms.

The medication is available as eye drops and is usually administered twice daily, according to the doctor's instructions. It is effective in preventing optic nerve damage and preserving vision.

Side effects may include burning or stinging sensation in the eyes, bitter taste, dry eyes, fatigue, and, in rare cases, allergic reactions. Regular monitoring of intraocular pressure is essential.

Consult your doctor to discuss the benefits and risks of treatment with this combination. Follow the administration instructions to ensure treatment effectiveness.

General data about DORZOLAMIDA/TIMOLOL DR GERHARD MANN 20mg / 5mg / ml

  • Substance: dorzolamide + timolol
  • Date of latest medicines list: 01-07-2013
  • Product code: W57867001
  • Concentration: 20mg / 5mg / ml
  • Pharmaceutical form: ophthalmic drops solution
  • Quantity: 1
  • Product type: Generic medicine
  • Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

  • Manufacturer: DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH - GERMANIA
  • Holder: DR. GERHARD MANN CHEM.-PHARM.FABRIK GMBH - GERMANIA
  • Number: 9929/2017/01
  • Shelf life: 2 years-after packing for marketing; 28 days-after the first opening of the bottle

Pharmaceutical forms available for dorzolamide + timolol